$10,000 of SENSUS HEALTHCARE INC. lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Coverage and reimbursement for skin cancer treatments"
You can find more data on corporate lobbying on Quiver Quantitative.
SRTS Insider Trading Activity
SRTS insiders have traded $SRTS stock on the open market 2 times in the past 6 months. Of those trades, 2 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $SRTS stock by insiders over the last 6 months:
- MICHAEL SARDANO (PRESIDENT AND GENERAL COUNSEL) purchased 1,000 shares for an estimated $5,950
- JAVIER RAMPOLLA (CHIEF FINANCIAL OFFICER) purchased 501 shares for an estimated $2,980
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
SRTS Hedge Fund Activity
We have seen 27 institutional investors add shares of SRTS stock to their portfolio, and 43 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- KINGSTONE CAPITAL PARTNERS TEXAS, LLC added 668,880 shares (+inf%) to their portfolio in Q2 2025, for an estimated $3,170,491
- CITADEL ADVISORS LLC removed 197,205 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $932,779
- RENAISSANCE TECHNOLOGIES LLC removed 171,300 shares (-39.8%) from their portfolio in Q1 2025, for an estimated $810,249
- DIMENSIONAL FUND ADVISORS LP added 163,169 shares (+43.1%) to their portfolio in Q1 2025, for an estimated $771,789
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP removed 150,150 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $710,209
- ACADIAN ASSET MANAGEMENT LLC added 122,746 shares (+35.3%) to their portfolio in Q1 2025, for an estimated $580,588
- PACIFIC RIDGE CAPITAL PARTNERS, LLC added 114,500 shares (+inf%) to their portfolio in Q1 2025, for an estimated $541,585
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
SRTS Analyst Ratings
Wall Street analysts have issued reports on $SRTS in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Maxim Group issued a "Buy" rating on 05/19/2025
- HC Wainwright & Co. issued a "Buy" rating on 04/04/2025
- Lake Street issued a "Buy" rating on 03/11/2025
To track analyst ratings and price targets for SRTS, check out Quiver Quantitative's $SRTS forecast page.
SRTS Price Targets
Multiple analysts have issued price targets for $SRTS recently. We have seen 3 analysts offer price targets for $SRTS in the last 6 months, with a median target of $12.0.
Here are some recent targets:
- Anthony Vendetti from Maxim Group set a target price of $10.0 on 05/19/2025
- Yi Chen from HC Wainwright & Co. set a target price of $12.0 on 04/04/2025
- Ben Haynor from Lake Street set a target price of $13.0 on 03/11/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
